In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

Clinical and Experimental Metastasis

Volumn 15, Issue 3, 1997, Pages 246-258

  Wood, M ^a   Fudge, K ^a   Mohler, J L ^b   Frost, A R ^c   Garcia, F ^a   Wang, Min ^a   Stearns, M E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

in situ hybridization; metalloproteinases; prostate cancer; TIMPs

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR BINDING; SEMINAL VESICLE DISEASE;

COLLAGENASES; FOLLOW-UP STUDIES; GELATINASES; GLYCOPROTEINS; HUMANS; IN SITU HYBRIDIZATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM STAGING; PROSTATIC NEOPLASMS; PROTEINS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0030910423     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018421431388     Document Type: Article

References (38)

1. Foster SJ, Talbot IC, Claytin DG and Critchey DR, 1986, Tumor basement membrane laminin in adenocarcinoma of the rectum; an immunohistochemical study of biologic and clinical significance, Int J Cancer, 37, 813-17.
2. Daneker GG, Mercurio AM, Guerra L, et al. 1987, Laminin expression in colorectal carcinomas with varying degrees of differentiation. Arch Surg, 122, 1470-4.
3. Nakamura K, Mori M and Enjoji M, 1987. Distribution of basement membrane antigens in clinical gastric adenocarcinomas: an immunohistochemical study. J Clin Pathol, 40, 1418-23.
4. Liotta LA, Tryggvasonn K, Garbisa S, Hart I, Foltz CM and Shafie S, 1980, Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 284, 67-8.
5. Tarin D, Hoyt BJ and Evans DJ, 1982, Correlation of collagenase secretion with metastatic colonization potential in naturally occurring murine mammary tumors. Br J Cancer, 46, 266-78.
6. r72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res, 51, 439-44.
7. Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG, 1990. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol, 136. 585-92.
8. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG and Grigioni WF, 1991, Augmentation of type IV collagenase, laminin receptor and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol, 4, 239-42.
9. Irimura T, Yamori T, Bennett SC, Ota DM and Cleary KR, 1987, The relationship of collagenolytic activity to stage of human colorectal carcinoma. Int J Cancer, 40, 24-31.
10. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE and Turner DR, 1991, Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer, 49, 66-7.
11. Van Der Stappen JWJ, Hendriks T and Wobbes T, 1990, Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumours. Int J Cancer, 45, 1071-8.
12. Ogilvie SJ, Hailey JA, Juacaba SF, Lee ECG and Tarin D, 1985, Collagenase secretion by human breast neoplasms: a clinicopathologic investigation. J Nat Cancer Inst, 74, 19-28.
13. Liotta LA, Steeg P and Stetler-Stevenson W, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell, 64, 327-36.
14. Mignatti P, Robbins E and Rifkin DB, 1991, Tumor invasion through the human amniotic membrane: requirement for proteinase cascade. Cell, 47, 487-98.
15. Denhardt DT, Feng B, Dylan RE, Cocuzzi ET and Malyankar UM, 1993, Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmac Ther, 59, 329-41.
16. Sato T, Ito A, Mori Y, Yamashita K, Hayakawa T and Nagase HZ, 1993, Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Biochem J, 275, 645-50.
17. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D and Docherty AJP, 1992, The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metal-loproteinases. Biochem J, 283, 637-41.
18. Collier IE, Wilhelm SM, Eisen AZ et al. 1988, H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem, 263, 6579-87.
19. Ståhle-Bäckdahl M, Sudbeck BD, Eisen AZ, Welgus HG and Parks WC, 1992, Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J Invest Dermatol, 99, 497-503.
20. Docherty AJP, Lyoins A, Smith BJ, et al. 1985, Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature, 318, 66-9.
21. Leco KL, Hyden LJ, Sharma RR, Rocheleau H, Greenberg AH and Edwards DR, 1992. Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and HA-ras-transformed murine fibroblasts. Gene, 117, 209-17.
22. Larsson L-I. Christensen T and Dalboge H, 1988, Detection of propiomelanocortin mRNA by in situ hybridization using a biotinylated oligodeoxynucleotide probe and avidin-alkaline phosphatase histochemistry. Histochem, 89, 109-16.
23. Farquharson M, Harvie R and McNicol AM, 1990, Detection of messenger RNA using a digoxigenin end labeled oligonucleotide probe. J Clin Pathol, 43, 424-8.
24. Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawser MK and Bowden GT, 1991, Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol, 117, 144-50.
25. Lokeshwar BL, Selzer MG, Block NL and Gunja-Smith Z, 1993, Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in expiant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res, 53, 493-8.
26. Albini A, Iwamoto Y, Kleinman HK, et al. 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45.
27. 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Expression of mRNA of the seminal vesicle secretion protein II and androgen receptor genes in the rat prostate. Histochem, 98, 217-28.
28. Aznavoorian S, Murphy AN, Stetler-Stevenson WG and Liotta LA, 1993, Molecular aspects of tumor cell invasion and metastasis. Cancer, 71, 1368-82.
29. Kataoka H, DeCastro R, Zucker S and Biswas C, 1993, Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res, 53, 3154-8.
30. Sato H and Seiki M. 1993, Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395-405.
31. Autio-Harmainen H, Karttunen T, Hurskainen T, Höyhtyä M, Kauppila A and Tryggvason K, 1993, Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest, 69, 312-21.
32. Himelstein BP, Canete-Soler R, Bernhard EJ and Muschel RJ, 1994, Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci, 107, 477-86.
33. Pyke C, Ralfkiær E, Tryggvason K and Danø K, Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol, 142, 359-65.
34. Polette M, Clavel C, Cockett M, Girod de Bentzmann S, Murphy G and Birembaut P, 1993, Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis, 13, 31-7.
35. Basset P, Bellocq JP, Wolf C et al. 1990, A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348, 699-704.
36. Stetler-Stevenson WG, Brown P, Onisto M, Levy A and Liotta LA, 1990, Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem, 265, 13933-8.
37. Ponton A, Coulombe B and Skup D, 1991, Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res, 51, 2138-43.
38. Khokha R, Waterhouse P, Yagel S, et al. 1989, Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science, 243, 947-50.